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Abstract: MicroRNAs (miRNAs) are implicated in the epigenetic regulation of several 
brain developmental processes, such as neurogenesis, neuronal differentiation,  
neurite outgrowth, and synaptic plasticity. The main aim of this study was to evaluate 
whether miRNA expression profiling could be a useful approach to detect in vitro 
developmental neurotoxicity. For this purpose, we assessed the changes in miRNA 
expression caused by methyl mercury chloride (MeHgCl), a well-known developmental 
neurotoxicant, comparing carcinoma pluripotent stem cells (NT-2) with human embryonic 
stem cells (H9), both analyzed during the early stage of neural progenitor commitment into 
neuronal lineage. The data indicate the activation of two distinct miRNA signatures,  
one activated upon neuronal differentiation and another upon MeHgCl-induced toxicity. 
Particularly, exposure to MeHgCl elicited, in both neural models, the down-regulation  
of the same six out of the ten most up-regulated neuronal pathways, as shown by the  
up-regulation of the corresponding miRNAs and further assessment of gene ontology (GO) 
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term and pathway enrichment analysis. Importantly, some of these common miRNA-targeted 
pathways defined in both cell lines are known to play a role in critical developmental 
processes, specific for neuronal differentiation, such as axon guidance and  
neurotrophin-regulated signaling. The obtained results indicate that miRNAs expression 
profiling could be a promising tool to assess developmental neurotoxicity pathway 
perturbation, contributing towards improved predictive human toxicity testing. 
Keywords: miRNAs expression profiling; NT-2 and H9 cell lines; neuronal cultures; 
pathways of toxicity 
 
1. Introduction 
Neuronal gene expression is tightly regulated during development of central nervous system (CNS). 
Indeed, the process of neurogenesis requires the coordinated up regulation of neuronal genes and 
down-regulation of non-neuronal genes to ensure the proper timing of differentiation and correct 
number of neurons. Recently, a great deal of evidence showed that gene expression regulation 
includes, not only transcription factors, but also small regulatory RNAs, such as microRNAs 
(miRNAs), which play an important role in the establishment and maintenance of cell identity, 
neuronal and glial differentiation, axonal path-finding, neuronal patterning, and plasticity [1–3]. 
miRNAs introduce an additional layer of post-transcriptional regulatory control of gene expression 
since each miRNA can target up to a few hundred target genes, resulting in the regulation of as much 
as one third of the protein expression in animals [4]. 
The role of miRNAs in brain development has been studied by analyzing the effects of the genomic 
Dicer ablation, which results in the absence of all mature miRNAs. In mice, Dicer ablation causes 
neurodegeneration of dopaminergic neurons in the midbrain [5] and Dicer silencing in neocortical 
progenitors impairs neuronal differentiation [6] and results in abnormal terminal differentiation of 
developing olfactory progenitors. Severe brain morphogenesis deficits were also observed in zebrafish 
Dicer knockout mutants [7]. 
Several miRNAs have been found to play important roles in the nervous system. The brain specific 
miRNA-9 targets the stathmin mRNA and has been implicated in early neurogenesis, promoting cell 
proliferation while decreasing neural progenitors migration [8,9]. Another brain specific miRNA is 
miRNA-124, known to be involved in neuronal differentiation [10]. 
Numerous miRNAs, including miRNA-134, have been reported to play an important role in 
modulation of spines and dendrites development [11] and others, such as miRNA-132 [12] and 
miRNA-388, affect neurite outgrowth, branching synaptic plasticity, and memory function [1].  
There are a few identified miRNAs (miRNAs-284, miRNA-138, miRNA-1) that have been implicated 
in synaptic formation and plasticity [1], as well as in the establishment of neuronal connectivity  
(such as miRNA-206, let-7 or miRNA-125a), which plays an important role in learning and memory 
processes [13,14]. The above-mentioned studies suggest that miRNAs are heavily involved in the 
regulation of neuronal development at different stages of cell differentiation and maturation. 
Moreover, it is well known that abnormal miRNA expression resulting in aberrant expression of target 
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mRNAs can take place during neurodegenerative disorders or as a result of chemically induced 
neurotoxicity [15]. For instance, miRNA-19, -101, and -130 have been shown to regulate the 
expression of genes involved in spino-cerebellar ataxia [16] and miRNA-107 is involved in the 
pathophysiology of Alzheimer's disease [17]. The main aim of this study was to evaluate whether the 
analysis of the dysregulation of miRNA expression profiles induced by the exposure to an environmental 
chemical, could be a useful tool for developmental neurotoxicity testing (DNT) using an in vitro 
approach. Therefore, to identify the possible DNT biomarkers among deregulated miRNAs, we have 
firstly studied the changes in miRNA expression during the process of neuronal differentiation in the 
neuronal cultures derived from H9 or NT-2 cell lines and then compared the miRNA expression 
profiles in the same cell lines observed after exposure to a non-cytotoxic concentration of methyl 
mercury chloride (MeHgCl). MeHgCl is a well-known DNT chemical that disturbs the process  
of neuronal differentiation, synapse formation and causes damage to the process of learning and 
memory [18–20]. The exposure to MeHgCl was performed during the early stages of the neuronal 
differentiation process (i.e., 1–36 days in vitro (DIV) for NT-2 cells and 1–10 DIV for H9 cells) since 
previous in vitro studies from our laboratory [19,20] and epidemiological evidence [21–24] indicate 
that, compared to the adult CNS, the early stages of brain development are more susceptible to 
toxicants. Moreover, the early exposure of neural progenitor cells to chemicals seems to be a more 
vulnerable time period than the later stages of neuronal differentiation [25,26]. Indeed, human 
embryonic stem cells (hESCs), at the stage of the neural precursor formation, have been shown to be 
affected by non-cytotoxic concentrations of MeHgCl [26,27]. 
In these studies we have compared the miRNA expression profile of the control neuronal cultures 
derived from two different sources of human stem cells, pluripotent embryonic carcinoma (NT2 cell line) 
with embryonic stem cells (H9 cell line) both assessed against their respective undifferentiated and 
differentiated counterparts. At the next stage, the changes in the expression of miRNA expression were 
evaluated after exposure to MetHgCl, possibly contributing to the identification of novel biomarkers 
for neurodevelopmental toxicity, implementing the knowledge of the molecular mechanisms 
implicated in human toxicology. 
Currently, different types of human stem cell models are widely used for basic research, 
regenerative medicine and toxicological studies; however, works addressing comparative analyses of 
the proposed models, especially for toxicological applications, are mostly missing. Recently,  
human pluripotent stem cells (hPSCs) and their derivatives have been considered as valuable cellular 
tools to implement in current toxicity testing [28–30]. Particularly, these cells can be efficiently 
differentiated towards several cell types, including neuronal and glial-like cells, representing valid 
tools to study both developmental and adult neurotoxicity [29,31]. 
As characterized in our previous studies, the human pluripotent carcinoma stem cell line NT2 cell 
line, in the presence of retinoic acid (RA), can be differentiated into post-mitotic neurons expressing 
MAP2, NF200, neuronal class Tub-βIII, MAPT-Tau, synaptophysin, and other proteins [32]. 
Furthermore, under specific culture conditions, the NT2-derived neurons can form functional synapses [33] 
and express a variety of synapse formation markers and neurotransmitters phenotypes [34]. Similarly, 
the H9 cell line can be committed toward neural progenitors [26] and further differentiated towards 
neuronal and glial phenotype [29,35]. 
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In this study, we have analyzed the mRNA and miRNA expression profiles comparing NT-2 and 
H9 cells undergoing early neural commitment, followed by the evaluation of the effects elicited by  
a repeated administration of MeHgCl. Data indicate the downregulation of common neuronally related 
signaling pathways in both cellular models, as highlighted by miRNAs/mRNA gene ontology analyses. 
This knowledge might contribute to the development of a new class of toxicological in vitro tests, 
leading to the design of a novel mechanistic toxicology, based on human in vitro models. In this 
context, miRNA profiling could provide functional information on cellular physiological pathways that 
when significantly perturbed by the exposure to a chemical, might be acknowledged as toxicity 
pathways involved in developmental neurotoxicity. 
2. Materials and Methods 
2.1. H9 and NT-2 Cell Maintenance and Differentiation towards Neuronal Phenotype 
Both types of pluripotent stem cells were triggered to differentiate into neuronal-like cells following 
well-established protocols. Undifferentiated human embryonic stem cells (H9, hESCs) (WiCell MOU 
02-W177 SLA 10-W0409) were cultured and committed toward neural precursor cells for 10 DIV, 
followed up to full post-mitotic neuronal differentiation (28 DIV) as previously described [26]. Briefly, 
NIH-registered H9 cells were cultured at 37 °C and 5% CO2 in maintenance medium (DMEM/F12 
supplemented with 20% knock out serum replacement, 1% non-essential amino acids, 50 U/mL 
penicillin and 50 μg/mL streptomycin, 2 mM glutamine, 0.1 mM β-mercaptoethanol (all from 
Invitrogen, Carlsbad, CA, USA) and 8 ng/mL of human basic fibroblast growth factor (bFGF, 
Immunological Sciences, Rome, Italy). H9 cells were sub-cultured weekly by microdissection and 
propagated on mitomycin-inactivated human feeder fibroblasts (hDFn, Gibco, Cascade Biologics, 
Carlsbad, CA, USA), which have been plated on 0.1% gelatin (Sigma Aldrich, St. Louis, MO, USA),  
diluted in 1× PBS (Gibco, Life Technologies, Carlsbad, CA, USA) at a plating density of about  
15,000 cells/cm
2
. 
Further differentiation of neural precursors was performed as follows: intact H9 colonies were 
detached by 1 mg/mL collagenase (Invitrogen, Carlsbad, CA, USA) and cultured in suspension in 
maintenance medium without bFGF to allow embryoid body (EB) formation. Each EB was transferred 
onto a single well in 10 μg/mL laminin-coated black, clear-bottom 96-well plates (Perkin Elmer 
ViewPlate-96F Cat No. 6005225, Waltham, MA, USA), containing neural induction (NI) medium 
(DMEM/F12 supplemented with 1% nonessential amino acids, 1% N2 supplement (Invitrogen, 
Carlsbad, CA, USA), and 2 μg/mL heparin (Sigma, St. Louis, MO, USA) and 20 ng/mL bFGF. 
Cultures were observed daily and medium was changed every third day for 10 days. During this time, 
neuroepithelial aggregates, called rosettes, became visible. To promote the full maturation of the 
neuroepithelial cells into mature neurons, rosettes were cut into fragments using a 30 G needle and 
p100 μL tip, using a phase contrast microscope under sterile conditions. Fragments were replated on 
laminin-coated dishes in presence of neuronal differentiation medium (ND, Neural progenitor cell 
basal medium, supplemented with NPDM Bulletkit, 1 ng/mL GDNF and 2.5 ng/mL BDNF) and 
cultured for at least 3 additional weeks. 
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NTERA-2/cl.D1 cells were differentiated into neurons as previously described in [32]. Briefly, 
undifferentiated NT-2 cells (ATCC) were cultured in standard tissue culture flasks (Nunc, Rochester, 
NY, USA) and maintained in Opti-MEM I (Gibco, Carlsbad, CA, USA) supplemented with 5% fetal 
bovine serum (FBS) (HyClone, Waltham, MA, USA), 100 U/mL penicillin (P), and 100 μg/mL 
streptomycin (S) (Gibco, Carlsbad, CA, USA). The differentiation process was performed by culturing 
the cells in Dulbecco’s modified Eagle’s Medium-High Glucose (DMEM-HG) (Gibco, Carlsbad, CA, 
USA) supplemented with 10% FBS, 1% P/S, and 10 μM retinoic acid (RA) (Sigma, St. Louis, MO, 
USA) up to 36 DIV at 37 °C in a humidified atmosphere of 5% of CO2. To obtain fully differentiated 
neurons, the cells were trypsinized at 36 DIV, and split in standard medium (DMEM-HG with  
5% FBS, P/S) supplemented with a mixture of mitosis inhibitors composed of 1 μM cytosine 
arabinoside (Sigma, St. Louis, MO, USA), 10 μM fluorodeoxyuridine (Sigma, St. Louis, MO, USA), 
and 10 μM uridine (Sigma, St. Louis, MO, USA). Cells were then seeded in plates coated with  
10 μg/mL poly-D-lysine (Sigma, St. Louis, MO, USA) and 0.26 mg/mL Matrigel and cultured for the 
next 8 weeks (up to 96 DIV) at 37 °C in a humidified atmosphere of 5% of CO2. The medium was 
changed twice per week. 
2.2. Immunocytochemistry 
Fully differentiated H9 cells (28 DIV) and fully differentiated NT-2 cells (96 DIV) were fixed with 
4% formaldehyde (Sigma, St. Louis, MO, USA) for 20 min at room temperature. After three washes 
with PBS buffer (Invitrogen, Carlsbad, CA, USA), the cells were permeabilized for 15 min with  
0.4% Triton X-100 (Sigma, St. Louis, MO, USA). Blocking was done using 3% of BSA (Sigma,  
St. Louis, MO, USA) in PBS for 30 minutes at room temperature. The blocking buffer was removed 
by aspiration and replaced by primary antibodies against the neural stem cell marker nestin (Sigma,  
St. Louis, MO, USA, rabbit, 1:200) or neurofilament 200 (NF-200, Sigma, St. Louis, MO, USA, 
rabbit, 1:1000), diluted in 3% BSA-blocking buffer. Plates were incubated for 1 h at 37 °C or 
overnight at 4 °C. Stained cells were then rinsed with 1× PBS buffer and further incubated for 30 min 
at room temperature with the appropriate fluorescent-conjugated secondary antibodies (Alexa  
Fluor-488 goat anti-rabbit IgG (H + L), 1:1000, and Alexa Fluor-546 goat anti-mouse IgG (H + L), 
1:1000) and nuclei were counterstained by using DAPI dye (0.3 μM, Sigma, St. Louis, MO, USA). 
Controls for specificity of immunostaining were performed by omitting the primary antibody from  
the procedure. All stained cultures were examined by fluorescent microscope (Olympus 1 × 70,  
Tokyo, Japan). 
2.3. Cell Viability Assay Using Alamar Blue (AB) 
Cell viability was determined once a week during the five-week-long treatment of NT-2 cells with 
100, 200, 400 and 500 nM MeHgCl, using the AB (resazurine) assay [36]. The blue colored indicator 
dye resazurin is reduced into fluorescent resorufin by red-ox reactions in viable cells. Resazurin (10 μL 
of 100 μM stock) in Hank’s Buffered Salt Solution was added directly to the 96-well plates,  
without removing the medium (100 μL). The plate was incubated for 6 h at 37 °C, 5% CO2.  
After the incubation period, the fluorescence of the resazurin metabolite (resorufin) was measured at 
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530 nm/590 nm (excitation/emission) in a multi-well fluorometric reader (Tecan i-control, Shanghai, 
China). The results were expressed as a percentage of the mean value for the untreated cultures. 
The same AB assay was performed on differentiated H9 cells only once after the 10 days of 
exposure to 25 nM MeHgCl, in order to ensure that it was not a cytotoxic concentration. 
2.4. Exposure to Methyl Mercury Chloride 
Neural differentiating hESCs (H9 cell line) were exposed to a non-cytotoxic concentration  
(based on Alamar Blue assay, data not shown) of MeHgCl (25 nM, Sigma, St. Louis, MO, USA). 
Chemical exposure began 24 h after EB plating (day 1 of differentiation). Both chemical and medium 
were refreshed every third day along the neural commitment process, allowing a repeated exposure to 
the chemical. Exposure lasted 10 days; on day 10, samples were harvested for mRNAs and  
miRNAs analyses. 
Analogously, NT-2 cells were exposed to a non-cytotoxic concentration (based on Alamar Blue  
assay, [36]) of MeHgCl (400 nM, Sigma, St. Louis, MO, USA) from 2–36 DIV during the cell 
differentiation process and both medium and chemical treatment were refreshed twice a week.  
Three biological replicates were performed per each experimental condition (control and treated cells). 
2.5. RNA Extraction and miRNAs Expression Analysis 
RNA was extracted from untreated and MeHgCl treated cell samples using the MIRVANA kit 
(AMBION, Foster City, CA, USA) according to manufacturer’s instructions. This kit allows the 
isolation of total RNA enriched with miRNAs. RNA concentration and quality were determined by 
Nanodrop (Thermo Fisher Scientific, Boston, MA, USA) and 2100 Agilent Bioanalizer (Agilent 
Genomics, Santa Clara, CA, USA). The RIN was always above 8.5. 
Total RNA was reverse transcribed with Taqman MicroRNA Reverse Transcription Kit using 
Megaplex
TM
 RT Primers (Applied Biosystems, Carlsbad, CA, USA). Real Time PCR reactions were 
carried out on pre-configured microfluidic cards (Taqman Array MicroRNA Cards, set A,V2.2, 
Applied Biosystems, Carlsbad, CA, USA) allowing the detection of about specific 380 unique assays 
and four candidate endogenous control assays. The microfluidic cards were evaluated with Applied 
Biosystems 7900HT Sequence Detection system (Applied Biosystems, Carlsbad, CA, USA). For  
H9 cell line, two independent RNA samples per group were obtained by pooling 16 biological replicates  
(i.e., individual EBs pooled together); for NT-2 cell line, three biological replicates were performed for 
every experimental condition. 
2.6. Analysis of Stemness Marker Expression 
The expression of a set of genes known as stemness markers specific for hESCs was evaluated 
using TaqMan
®
 Human Stem Cell Pluripotency microfluidic cards (Applied Biosystems, Carlsbad, 
CA, USA). The expression of 90 well-defined genes validated as markers for pluripotency and 
differentiation, together with 6 endogenous controls, was evaluated after retro-transcription of total 
RNA in cDNA by using the High Capacity cDNA reverse Transcription Kit (Applied Biosystems, 
Carlsbad, CA, USA). The microfluidic cards were analysed with Applied Biosystems 7900HT 
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Sequence Detection system (Applied Biosystems, Carlsbad, CA, USA). Each measurement was 
performed in two independent experiments for NT-2 and H9 cell lines, two independent RNA samples 
per group were obtained by pooling 16 biological replicates. 
2.7. Statistical Analysis of miRNA Expression 
Experimental data were then analyzed by SDS 2.3 software (Applied Biosystems, Carlsbad, CA, 
USA). The Ct values were exported from SDS 2.3 software (Applied Biosystems, Carlsbad, CA, USA) 
and used as raw data for analysis of qRTPCR data. The R software (version 3.0.2, Vienna, Austria, 
2013) [37] and the packages HTqPCR [38] and Limma [39] were used for the manipulation and 
analysis of the Ct values. 
Statistical significance was assessed using Limma (linear models in micro-array analysis) in 
HTqPCR. Statistical comparisons were generated for differentiated neuronal cultures samples between 
the treated and control samples. Detectors that showed a fold change greater than 2 or less than 0.5, 
with a p-value smaller than 0.05, were considered as differentially expressed. 
2.8. Gene Ontology (GO) Term Enrichment Analysis 
The miRecords database [40] was used to identify the predicted targets for regulated microRNA 
that were further analyzed for identification of pathways enrichment. 
MiRecords stores predicted miRNA targets produced by 11 established miRNA target prediction 
programs (DIANA-microT, MicroInspector, miRanda, MirTarget2, miTarget, NBmiRTar, PicTar, 
PITA, RNA22, RNAhybrid, and TargetScan.). In the miRecords database, we considered as predicted 
when they were identified as targets by at least five different algorithms. 
The targets were organized in three lists: targets of up-regulated miRNA in H9 cells by MeHgCl 
treatments, targets of up-regulated miRNA in NT-2 cells after MeHgCl treatments and targets of 
down-regulated miRNA in NT-2 cells after exposure to MeHgCl. 
The further analysis of the three gene lists was conducted online using WEB-based GEne SeT 
AnaLysis Toolkit (WebGestalt) [14]. For term enrichment analysis defaults settings were applied. 
3. Results 
3.1. Characterization of H9 and NT2 Cells Differentiation towards Neuronal Phenotype 
The H9 human pluripotent embryonic stem cell line and the NT-2 pluripotent human testicular 
embryonic carcinoma cell line were differentiated towards the neuronal lineage using two different 
protocols (see Materials and Methods, section 2.1). Rosette formation in H9 cell culture was observed 
by phase contrast microscope between 8–10 DIV (Figure 1A). After 28 DIV, the presence of 
differentiated neuronal-like cells, creating a dense network of neurites, was confirmed by staining with 
the neuronal differentiation marker NF-200 (Figure 1B). The detailed characterization of neuronal 
differentiation kinetics of H9 cell line was previously described [26]. 
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Figure 1. Neural differentiation verified by phase-contrast microscope and  
immuno-cytochemistry staining. (A) Differentiation process triggered the formation of 
neural rosettes in H9 cell culture (at passage 35), already detectable on 10 DIV (phase 
contrast, magnification 10×); (B) At 28 DIV a dense network of neurites was visualized in 
H9 cell line by staining against NF-200 (green) and DAPI (blue) (fluorescent microscopy) 
(at passage 35, magnification 10×). The table presents the process of neuronal differentiation 
(the applied media, differentiation factors and type of coating; NI-Neural Induction 
medium, ND-Neuronal Differentiation medium); (C) The differentiation towards neuronal 
phenotype of NT-2 cell line was triggered by the exposure to 10 μM retinoic acid up to 36 DIV 
(phase contrast, magnification 20×); (D) The process of neuronal differentiation of NT2 
cells was followed up to 96 DIV. At this time point, groups of neurons (nuclei stained by 
DAPI, blue) were linked by a dense network of neurites, positively stained against NF-200 
(green, fluorescent microscopy, magnification 40×). The table presents the process of 
neuronal differentiation (the applied media, differentiation factors, and type of coating;  
NI-Neural Induction medium, ND-Neuronal Differentiation medium). 
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The NT-2 pluripotent human testicular embryonic carcinoma cell line was differentiated toward 
neuronal phenotype following the procedure described in our previous studies [32]. For the purpose of 
this work we tried to match the first stage of cell differentiation between these two models and focused 
only on the initial process of neural precursors differentiation. According to our data sets, the first 10 days 
of differentiation of H9 cells in the presence of NI medium corresponded approximately to 36 days of 
differentiation of NT-2 cells in the presence of RA. Indeed, rosette-like structures of H9 cell line at  
10 DIV possessed cells predominantly nestin positive indicating the presence of neural progenitors 
(data not shown). Similarly, NT-2 cells at 36 DIV (in the presence of RA) were also mainly positive 
for nestin (data not shown) confirming the presence of neural precursor cells committed to neuronal 
lineage. Based on these results, we considered NT-2 cells at 36 DIV and H9 cell line at 10 DIV being 
at similar stage of differentiation, consisting mainly of neural progenitor cells (nestin-positive cells). 
After 36 DIV in the presence of RA, NT-2 cells started to form a very dense multilayered neuronal 
culture (Figure 1C). After this stage, the exposure to mitosis inhibitors (until 96 DIV) allowed to obtain 
a fully matured, mixed neuronal/glial population of cells characterized in our previous studies [32].  
At 96 DIV the presence of large cell aggregates was observed, which were linked to each other by 
neurite bundles, forming a dense neuronal network, positively stained for NF-200 (Figure 1D).  
The process of neuronal differentiation was followed up to 96 DIV and up to 28 DIV in the case of 
NT-2 and H9 cell lines, respectively. The final stage of post-mitotic neuronal differentiation was found 
to be comparable between NT-2 derived neuronal-like cells and H9-derived neuronal culture, as shown 
by cell morphology based on staining against NF-200 for both cell lines (Figure 1B,D) and expression 
of specific neuronal markers at mRNA and protein levels [32,35]. 
3.2. Gene Expression Analysis Comparing Neuronal Committed H9 and Neuronal Committed  
NT-2 Cells 
In order to compare the early stage of the differentiation process, the expression levels  
of 90 different genes were analyzed using the ―TaqMan Human Stem Cell pluripotency microfluidic card‖ 
in the two cell lines. This card allows the simultaneous analysis of genes validated as characteristic markers 
of human stem cells or of the three embryonic germ layers. Based on the performed analysis, the 
overexpression of 27 and 28 genes was identified, respectively in the differentiated H9 (DIV 10) and NT-2 
cells (DIV 36). Among these genes, five were significantly up-regulated in both cell lines (COL2A1, FN1, 
GATA6, IAPP and SYP) compared to their respective undifferentiated counterparts (Figure 2A,B). 
The zinc finger transcription factor GATA6 plays a crucial role during early embryogenesis of 
vertebrate development; the alpha-1 chain of type II collagen (COL2A1) is defined as a mesodermal 
marker; fibronectin (FN1) is involved in cell adhesion and migration processes, including 
embryogenesis; the islet amyloid polypeptide (IAPP) is expressed during the embryonic development 
of the pancreas; synaptophysin (SYP) is an integral membrane protein of small synaptic vesicles found 
in brain and endocrine cells. 
In contrast, 29 and 28 genes were down-regulated upon neuronal commitment respectively in H9 
and NT-2 cells. Amongst these, six genes (i.e., DNMT3B, EOMES, FGF4, LIN28, SFRP2 and SOX2) 
were down-regulated in both cell lines (Figure 3A,B). 
Toxics 2014, 2 452 
 
 
Figure 2. Comparison of mRNA expression of up-regulated stemness phenotype markers 
in H9 and NT-2 cells upon neural differentiation. (A) The comparison between the number 
of up-regulated genes in H9 at 10 DIV (blue) and in NT-2 at 36 DIV (red) cell line 
(compared to undifferentiated cells) illustrated by the use of Venn diagrams. Among the 
upregulated genes five of them (COL2A1, FN1, GATA6, IAPP, and SYP) were overlapping 
being over-expressed in both cell systems; (B) The fold change of the gene expression of 
the five up-regulated genes overlapping between the differentiated H9 and NT2 cell 
cultures has been quantified by using TaqMan
®
 Human Stem Cell Pluripotency 
microfluidic cards. 
(A) (B) 
 
 
Figure 3. Comparison of mRNA expression of down-regulated stemness phenotype 
markers in H9 and NT-2 cells upon neural differentiation. (A) The genes expression 
overlapping between H9 and NT-2 cell lines represented by the use of Venn diagrams, 
showing the number of down-regulated genes in H9 (green) and in NT-2 (yellow);  
(B) The expression of the same six genes was down-regulated in both cell systems (H9 and 
NT-2) when compared with their fold change to the expression level in undifferentiated 
cell cultures by using TaqMan
®
 Human Stem Cell Pluripotency microfluidic cards. 
(A) (B) 
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With the exception of EOMES, a trophoblast marker, other genes were correlated to stemness 
properties and phenotype. DNMT3B, a DNA methyltransferase, is known to play an important role in 
embryonic development of undifferentiated hESCs; the transcription factor SOX2 is involved  
in the regulation of embryonic development, in the determination of cell fate and pluripotency 
maintenance activity; while the genes FGF4, LIN28, and SFRP2 have been characterized as  
stemness markers [41,42]. 
Figure 4. Comparison of miRNA expression level between H9 and NT-2 cell lines upon 
neuronal differentiation. miRNA expression overlapping between these two cell lines is 
shown for up-regulated (A) and down-regulated (B) miRNAs by using of Venn diagram; 
(C) The quantification of the expression levels of the most significantly deregulated and 
overlapping miRNAs during the process of neural differentiation in H9 and NT-2 cells. 
Data are expressed in log2 FC (fold change), comparing differentiated to undifferentiated 
cell samples. miRNAs specific for stemness were down-regulated during the differentiation 
process (negative fold change), whereas miRNAs specific for neuronal differentiation 
showed an increase of their expression in the differentiated cells (positive fold change) 
compared to undifferentiated cells. 
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3.3. Comparison of miRNA Expression Profiles between Neuronal Committed H9 and  
Neuronal Committed NT-2 Cells 
The variation in the expression of 381 miRNAs was measured by using microfluidic cards  
―Taqman Array MicroRNA Cards‖ (Applied Biosystems, Carlsbad, CA, USA) and comparing 
undifferentiated NT-2 and undifferentiated H9 cells (both at 1 DIV) with their respective neuronal 
committed counterparts, respectively at 36 DIV for NT-2 and at 10 DIV for H9. 
Thirty-two miRNAs were significantly upregulated in both differentiated H9 and NT-2 cell lines 
(about 40% of the total up-regulated miRNAs) (Figure 4A). Six miRNAs (i.e., miR-520g, miR-518b, 
miR-517c, miR-302a, miR-302b, and miR-302c) were down-regulated during the differentiation 
process in both cell lines, representing 50%–75% of the total miRNAs respectively down-regulated in 
H9 and NT-2 cells (Figure 4B). 
As expected, in both test systems we observed the down-regulation of the expression of the 
stemness-specific miRNA-302 family and the up-regulation of miRNAs known to be involved in  
the neuronal differentiation process, particularly miR-133a, miR-125 and miR-342 (Figure 4C).  
The obtained results indicated that these different cellular models are comparable as they are 
characterized by the expression of common miRNA expression profiles during the process of 
differentiation towards the neuronal phenotype. 
3.4. Analysis of miRNA Expression Profile Perturbations Comparing Neuronal Committed H9 and 
Neuronal Committed NT-2 Cells Exposed to MeHgCl 
In order to compare the miRNA deregulation induced by MeHgCl exposure, which is a well-known 
developmental neurotoxicant, cells were treated during the initial differentiation process (see Materials 
and Methods, section 2.4) and the miRNA expression was analyzed by using microfluidic cards 
―Taqman Array MicroRNA Cards‖ (Applied Biosystems, Carlsbad, CA, USA). The non-cytotoxic 
concentrations of MeHgCl were chosen based on the cytotoxicity studies (Alamar Blue assay) 
performed on H9 and NT-2 cell lines. Accordingly, H9 cells were treated with 25 nM MeHgCl 
(between 1–10 DIV) while NT-2 were exposed to a concentration of 400 nM (2–36 DIV). The time of 
exposure to MeHgCl differs as it was adjusted to the neuronal differentiation protocol established for 
these two cell lines (Figure 1). Interestingly, in H9 cells undergoing neuronal commitment, MeHgCl 
repeated dose exposure induced a significant up-regulation of three miRNAs, miR-183, miR-15a and 
miR-526b*. The miR-183 was previously found to be up-regulated in undifferentiated hESC lines [43], 
while miR-15a seemed to be relevant in hearth development [44]. In the case of NT-2 cell line 
undergoing differentiation in presence of RA, MeHgCl treatment induced the deregulation of several 
miRNAs; nine of them were up-regulated (miR-141, miR-196b, miR-367, miR-302b, miR-372,  
miR-302a, miR-302c) and five down-regulated (miR-296, miR-217*, miR-655, miR-365, miR-181a)  
(Table 1). Indeed, the impairment of the differentiation process was reflected by the increased 
expression of stemness-related miRNAs, such as miR-302/367 cluster, miR-372 and miR-141. On the 
other hand, we observed the down-regulation of miRNAs, such as miR-296, miR-217, miR-655,  
miR-365, and miR-181a. Interestingly, amongst them, miR-296 is known to target the stemness-specific 
transcription factor NANOG [45] as described before [46]. Increased expression of NANOG indicates 
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again the disturbance of differentiation process towards neuronal phenotype induced by MeHgCl. 
Indeed, the miRNA-296 was shown to be up-regulated in mouse ESC upon RA-induced differentiation, 
confirming that decreased expression of NANOG is taking place during the process of neuronal 
differentiation [45]. 
Table 1. List of miRNAs up- or down-regulated upon toxic treatment with methylmercury 
chloride (MeHgCl) in H9 and NT-2 cell lines. H9 cells were exposed to 25 nM MeHgCl 
during the first 10 days of differentiation. NT-2 cells were exposed to 400 nM MeHgCl 
from 2 to 36 DIV. The fold change (FC) of miRNA expression compared to respective 
untreated control is indicated for each miRNA (down-regulated miRNAs are reported in 
italic letters). 
Cell Line MeHgCl Treatment miRNA FC p-value 
H9 
Time: DIV 1–10;  
Concentration: 25 nM 
miR-183 2.82 <0.05 
miR-15a 19 <0.05 
miR-526b* 6.5 <0.05 
NT-2 
Time: DIV 2–36  
Concentration: 400 nM 
miRNA-141 2.5 <0.05 
miRNA-196b 3.2 <0.05 
miRNA-367 6.1 <0.05 
miRNA-302b 5.3 <0.05 
miRNA-372 9.5 <0.05 
miR-302a 3.7 <0.05 
miR-302c 3.1 <0.05 
miR-142 2.4 <0.05 
miR-200c 2.3 <0.05 
miR-296 −1.5 <0.05 
miR-217* −4.4 <0.05 
miR-655 −2.5 <0.05 
miR-365 −1.3 <0.05 
miR-181a −1.5 <0.05 
3.5. Gene ontology (GO) Term Enrichment Analysis of Deregulated miRNAs Induced by the Exposure 
to MeHgCl 
The targets of the deregulated miRNAs in both cell lines (H9 and NT-2) have been identified by the 
use of miRecords database and only the ones predicted by at least five different algorithms have been 
used for performing GO term enrichment analysis. For these miRNAs the WEB-Gestalt toolkit  
(WEB-based GEne SeT AnaLysis Toolkit, Vanderbilt University, Nashville, TN, USA) [14] has been 
then used in order to obtain the list of the most represented GO terms and pathways, which are the 
potential targets of deregulated miRNAs. The most significant GO terms were defined for the  
up-regulated miRNAs in the NT-2 and H9 cell systems, respectively (Table 2). No overlap has been 
observed between the general biological processes identified in these two cell lines. 
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Table 2. Enriched miRNA-biological process gene ontology (GO)-terms in NT-2 and H9 
cell lines. Analysis of Gene Ontology (GO) term enrichment for gene targets of deregulated 
miRNAs identified in the two cell cultures (H9 and NT-2) exposed to MeHgCl (compared 
to untreated cells). 
Upregulated miRNA-Biological Process GO-terms in NT-2 Cell Line p-value 
regulation of cellular macromolecule biosynthetic process (GO:2000112) 7.70 × 10−30 
regulation of cellular metabolic process (GO:0031323) 1.02 × 10−29 
regulation of cellular process (GO:0050794) 1.27 × 10−29 
regulation of macromolecule biosynthetic process (GO:0010556) 3.83 × 10−30 
regulation of macromolecule metabolic process (GO:0060255) 3.78 × 10−29 
regulation of nucleobase-containing compound metabolic process (GO:0019219) 7.70 × 10−30 
regulation of RNA metabolic process (GO:0051252) 5.38 × 10−29 
regulation of transcription from RNA polymerase II promoter (GO:0006357) 4.63 × 10−30 
regulation of transcription, DNA-dependent (GO:0006355) 4.36 × 10−29 
transcription from RNA polymerase II promoter (GO:0006366) 3.83 × 10−30 
Upregulated miRNA-Biological Process GO-terms in H9 Cell Line p-value 
anatomical structure morphogenesis (GO:0009653) 2.45 × 10−7 
cellular protein modification process (GO:0006464) 2.92 × 10−7 
generation of neurons (GO:0048699) 1.58 × 10−8 
nervous system development (GO:0007399) 1.58 × 10−8 
neurogenesis (GO:0022008) 1.58 × 10−8 
neuron differentiation (GO:0030182) 2.53 × 10−7 
protein modification process (GO:0036211) 2.92 × 10−7 
regulation of cell development (GO:0060284) 1.07 × 10−7 
regulation of cell differentiation (GO:0045595) 2.69 × 10−7 
regulation of developmental process (GO:0050793) 2.69 × 10−7 
Table 3. Enriched miRNA-pathways in NT-2 and H9 cell lines. Analysis of KEGG 
pathway enrichment for gene targets of regulated miRNAs identified in the cultures of the 
two cell types (H9 and NT-2) exposed to MeHgCl (compared to untreated cells).  
The overlapping pathways between H9 and NT-2 cell lines are marked in bold. 
Upregulated miRNA-Pathways  
in NT-2 Cell Line 
p-value 
Upregulated miRNA-Pathways  
in H9 Cell Line 
p-value 
Axon guidance 7.13 × 10−10 Cell cycle 4.36 × 10−6 
Pathways in cancer 4.86 × 10−15 Axon guidance 2.71 × 10−5 
Oocyte meiosis 3.85 × 10−10 TGF-beta signaling pathway 2.46 × 10−5 
MAPK signaling pathway 3.73 × 10−11 p53 signaling pathway 2.00 × 10−4 
Neurotrophin signaling pathway 3.38 × 10−14 Glycerophospholipid metabolism 1.00 × 10−4 
Renal cell carcinoma 1.89 × 10−8 Oocyte meiosis 8.25 × 10−6 
Wnt signaling pathway 1.70 × 10−9 Pathways in cancer 1.75 × 10−10 
Focal adhesion 9.74 × 10−10 Neurotrophin signaling pathway 1.22 × 10−6 
Ubiquitin mediated proteolysis 6.55 × 10−9 Wnt signaling pathway 1.22 × 10−6 
TGF-beta signaling pathway 4.94 × 10−9 Small cell lung cancer 1.00 × 10−4 
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However, interestingly, there is a strong overlap between the most enriched pathways (Table 3  
in bold) identified as being under the control of the analyzed up-regulated miRNAs in both NT-2 and 
H9 cell lines. 
Indeed six out of the ten most significantly up-regulated pathways are shared between the two tests 
systems. Some of these miRNAs are involved in regulation of pathways that are critical for cell-to-cell 
signaling during embryogenesis, such as Wnt signaling pathway, or involved in neuronal specific 
developmental processes, such as cell migration and neuronal differentiation, which are under the 
control of neurotrophin or more advanced neuronal specific maturation processes, such as the pathway 
involved in axonal guidance (Table 3). 
4. Discussion 
Recently in the field of regulatory toxicology, efforts have been undertaken towards more 
mechanistically driven approaches, aiming to improve current safety assessments of environmental 
chemicals, including those with neurodevelopmental potential [47]. 
The US National Research Council proposed a shift from the currently performed apical animal 
testing towards mechanistically-based toxicity pathways evaluation. It was advocated that such 
approaches should be based preferably on human cellular models, allowing the overcoming current 
shortcomings in the extrapolation between species [48,49]. In the field of adult and developmental 
neurotoxicity evaluation an attempt to apply the adverse outcome pathway (AOP) concept has been 
undertaken. The AOP framework is entirely based on mechanistic information capturing the key 
events from the initial molecular interaction of the toxicant with the biological target along the 
subsequent chain of events leading to an adverse outcome. Hopefully in the near future the AOP 
concept will serve as a basis for the development of testing strategies for human risk assessment [50]. 
In this study we have evaluated two human neuronal models derived from two different pluripotent 
stem cell sources, embryonic (H9 cell line) and carcinoma cells (NT-2 cell line) by comparing the 
expression of overlapping genes and miRNAs of undifferentiated cells versus those in the initial stage 
of differentiation towards neuronal phenotype. The detailed descriptions of the neuronal and glial 
markers characteristic of various differentiation stages of H9 and NT-2 cell line have been  
already published [26,32]. 
Interestingly, in this study upon neuronal differentiation an overlap between the up- (Figure 2) and 
down- (Figure 3) regulated genes in the human embryonic (H9) and carcinoma NT-2 cells was 
observed. As expected, the genes that were commonly up regulated in both models, such as COL2A1, 
FN1, GATA6, IAPP, and SYP were involved in the process of early embryogenesis and included SYP 
that is linked to neuronal differentiation. Moreover, DNMT3B, EOMES, FGF4, LIN28, SFRP2, and 
SOX2 genes, all linked to maintenance of stemness, were commonly down-regulated in both cell models. 
The presence of other genes differentially expressed in the two derived neuronal cell models,  
could be explained by the fact that these cell lines originate from very different types of stem cells, 
embryonic (H9) and carcinoma (NT-2) cells, and the neuronal differentiation protocols designed to 
promote their neuronal commitment are necessary different. 
As miRNAs have been demonstrated to play crucial roles in nervous system development in vivo, 
we sought to evaluate miRNA expression profiles comparing the two neuronally committed cell 
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models (NT-2 and H9). Both models underwent a significant miRNA expression regulation upon 
neuronal commitment. Indeed, 32 miRNAs were commonly up regulated in both models and the most 
significantly overexpressed were miR-133a, miR125b, miR125a-5p and miR342-3p (Figure 4),  
which are known to be involved in neuronal differentiation. In contrast, in both cell lines,  
only six miRNAs were commonly down-regulated, and all these miRNAs are known to be related to 
stemness maintenance. In particular, the miRNA-302 family (302c, 302a, 302b) that is known to be 
involved in the regulation of pluripotency maintenance, was found significantly down-regulated during 
the neuronal differentiation process. 
Furthermore, we evaluated whether the expression of these miRNAs was deregulated after the 
exposure to MeHgCl, aiming to identify possible biomarkers of in vitro induced developmental 
neurotoxicity. Indeed, miRNAs are supposed to regulate numerous target genes involved in the control 
of stress response pathways, and it could be useful to identify chemically perturbed pathways specific 
for neurodevelopmental toxicity. 
Therefore, after repeated exposure to non-cytotoxic concentration of MeHgCl (25 nM) during the 
initial stage (1-10 DIV) of neural differentiation of H9 cell line, we identified three miRNAs that were 
significantly up-regulated, such as miR-183 (fold change, FC 2.8), miR-15a (FC 19) and miR-526b 
(FC 6.5). Interestingly, expression of the miRNA-183 and -15a is linked to the non-neural 
differentiation processes, as miRNA-183 is highly expressed in embryonic stem cells [32] and 
miRNA-15a is involved in cardiac developmental differentiation. In the case of NT-2 cell line exposed 
to MeHgCl 400 nM, a significant up-regulation of the stemness related miRNAs was found  
(miR-302b, miR-367 and miR-372) suggesting that the process of neuronal differentiation could be 
affected. In agreement with this observation, we detected the down-regulation of the miRNA-296  
(FC 1.5), which is known to inhibit the expression of the stemness-related transcription factor  
NANOG [45]. We also observed down-regulation of miRNA-217 (FC 4.4), miRNA-655 (FC 2.5), 
miRNA -365 (FC 1.3) and miR-181a (FC 1.5), the involvement of which in cell differentiation or 
stemness phenotype maintenance was no previously observed. 
Interestingly, we did not observe any overlap between the deregulated miRNAs (up or down) 
determined in the H9 compared with NT-2 cell line exposed to MeHgCl. This may be explained by the 
fact that different protocols of cell differentiation had been applied and/or that these cellular models 
are derived from very diverse cellular sources (embryonic vs. carcinogenic). However, the different 
concentrations of toxicant were deliberately selected based on cytotoxicity assays (first non-cytotoxic 
concentration) and different time of exposure was selected based on the protocols of neuronal 
differentiation (see Materials and Methods). 
Furthermore, we performed GO terms enrichment analysis to identify the most represented 
biological processes and cellular pathways controlled by the miRNAs that were perturbed upon the 
exposure to MeHgCl. The biological processes that were under the control of the up-regulated 
miRNAs in NT-2 cell line were mainly correlated with the regulation of metabolic and macromolecule 
biosynthetic cellular processes, as well regulation of DNA-dependent transcription from RNA 
polymerase II promoter. Interestingly, the biological processes identified in the H9 cell line that were 
under control of the deregulated miRNAs were linked to neuronal specific developmental processes 
such as generation of neurons, nervous system development, neurogenesis, or regulation of developmental 
processes. Moreover, GO terms analysis for the most significantly up-regulated miRNAs in H9 and 
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NT-2 cells did not determine any overlap between the biological processes identified in these two cell 
lines. These results would suggest that at an early stage of differentiation, exposure to MeHgCl 
affected mainly the specific neurodevelopmental process of neural precursor cells derived from the H9 
cell line. In the case of the NT-2 cell line exposed to the same toxicant more general biological 
processes were affected, possibly due to a delay in neural differentiation when compared to H9 cell 
line. However, interestingly, NT-2 and H9 cell lines exposed to MeHgCl displayed a strong overlap of 
the most enriched pathways (Table 3), identified as being under the control of up-regulated miRNAs. 
Indeed, six out of the ten most significant pathways involved in the response to MeHgCl treatment are 
shared between the two test systems. Some of these common miRNA-targeted pathways could play  
a role in critical developmental processes, specific for neuronal differentiation, such as axonal 
guidance or neurotrophin-related signaling pathways. These results suggest that similar pathways are 
affected by MeHgCl exposure in both neural cultures derived from NT-2 or H9 (Table 3) and, most 
importantly, these pathways are specifically linked to neuronal cell function regulations. These 
comparative studies allowed us to conclude that miRNA deregulation induced by the exposure to 
MeHgCl perturbed similar neuronally related pathways in both H9 and NT-2 derived neuronal 
cultures, which might be consequentially identified as toxicity pathways. 
Although further investigation is necessary, the obtained results suggest that miRNA expression 
profiling could be used as a promising tool for simplified functional evaluation of the toxicity pathways 
involved in developmental neurotoxicity mechanisms and could improve predictive human toxicity 
testing, especially when human in vitro models are applied. However, taking into consideration the 
peculiar nature of pluripotent stem cells, a high level of standardization of undifferentiated and 
differentiated cell cultures is required [29] in order to ensure the robustness and reproducibility of 
results that in the future might serve for regulatory toxicology purposes. 
5. Conclusions 
The miRNA expression profiles have been compared during the early phase of neural commitment 
of the human pluripotent carcinoma (NT-2 cell line) and embryonic stem cells (H9 cell line). miRNas 
signatures were analyzed upon early stage of neural cell differentiation in the control cultures and after 
exposure to a repeated administration of MeHgCl at non-cytotoxic concentrations. The results obtained 
from this comparative study showed that miRNA deregulation induced by the exposure to MeHgCl 
perturbed similar pathways that were linked to specific neuronal differentiation processes in both 
cultures (derived from H9 or NT-2 cell lines). Comparison of miRNA profiles in these two in vitro 
DNT models strengthens the consideration to use this approach for identification and functional 
evaluation of toxicity pathways involved in developmental neurotoxicity mechanisms. Therefore 
miRNA profiling could represent a novel toxicological tool for detecting and characterizing human 
DNT hazards. 
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